Original Article
Copyright ©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2010; 16(46): 5815-5821
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5815
Table 1 Basic subject data (mean ± SD) n (%)
UC (n = 48)Controls (n = 47)
Age (yr)43.49 ± 15.4841.21 ± 15.36
Sex (M/F)21 (43.8)/27 (56.2)21 (44.7)/26 (55.3)
Age at diagnosis (yr)35.07 ± 14.39
Disease duration (yr)8.42 ± 8.49
Familial disease0 (0)0 (0)
Disease location
Proctitis3 (6.25)
Left colitis27 (56.3)
Right colitis1 (2.1)
Pancolitis17 (35.4)
Disease severity
Light17 (35.4)
Mild18 (37.5)
Severe13 (27.1)
History of colectomy5 (10.4)
History of immunosuppressant6 (12.5)
History of colon cancer3 (6.3)
Table 2 Primers used in polymerase chain reaction for genotyping Toll-like receptor 9 polymorphisms and three single nucleotide polymorphisms
Fragment (product)ForwardReverse
TLR9 polymorphisms
-2109 to -1293 (817 bp)5'-CCAAGGGACTCTGGGAAAG-3'5'-CATGTCACCCTCTCAACAGGG-3'
-1626 to -1095 (532 bp)5'-CAGCCTTCACTCAGAAATACCC-3'5'-GGCCAACAAGGCCCTATG-3'
-1296 to -553 (662 bp)5'-CATGGGAGCAGAGACATAATG-3'5'-GCCAGGGTGTAGCTTGA-3'
-795 to -134 (662 bp)5'-GAGTCTCCTCACCTAGATCAG-3'5'-TATACCAGCCTAGTAGC-3'
79 to 962 (884 bp)5'-CTGCAAGCAACAGTGACGG-3'5'-AGCTTTCACTTAACCAATCCC-3'
-393 to 1698 (2092 bp)5'-TACCCGCTACTGGTGCTATC-3'5'-TGGCAGAGTCTAGCATCAGG-3'
996 to 1687 (692 bp)5'-CTGGTTCTGAAGCCTAATTC-3'5'-AGCATGAGGATGTTGGTATGG-3'
976 to 1899 (924 bp)5'-CTGGATTCTAGGTCTCAGTCC-3'5'-CTGGATTCTAGGTCTCAGTCC-3'
1540 to 2368 (829 bp)5'-CCTGCCACATGACCATCGAG-3'5'-CCTGCCACATGACCATCGAG-3'
1812 to 2520 (709 bp)5'-AACCTCACCCACCTGTCAC-3'5'-AACCTCACCCACCTGTCAC-3'
2407 to 3350 (944 bp)5'-TGCAGATGAACTTCATCAACC-3'5'-GCTGTTGCAGCTGACATC-3'
3267 to 4057 (791 bp)5'-CAGGAAACCAGCTGAAGG-3'5'-CAGGAAACCAGCTGAAGG-3'
3867 to 4701 (835 bp)5'-GACTGGGTGTACAACGAGCTT-3'5'-TTCTGCATGGGAAAGGTAGG-3'
SNP
-14865'-CAGCCTTCACTCAGAAATACCC-3'5'-GGCCAACAAGGCCCTATG-3'
11745'-CTGGTTCTGAAGCCTAATTC-3'5'-AGCATGAGGATGTTGGTATGG-3'
28485'-TGCAGATGAACTTCATCAACC-3'5'-GCTGTTGCAGCTGACATC-3'
Table 3 Allele frequencies in ulcerative colitis cases and disease-free controls for Toll-like receptor 9 single nucleotide polymorphisms at -1486, 1174, 2848
SNP1AlleleUC (n = 48)Controls (n = 47)dbSNP2JSNP3
-1486T/C0.344/0.656a0.532/0.4680.647/0.353ND
1174A/G0.344/0.656a0.532/0.4680.512/0.4880.517/0.483
2848G/A0.354/0.646a0.543/0.4570.481/0.5190.517/0.483
aP = 0.013
Table 4 Genotype frequencies in ulcerative colitis cases and disease-free controls for Toll-like receptor 9 single nucleotide polymorphisms at -1486, 1174, 2848 n (%)
Genotype at TLR9UC (n = 48)Controls (n = 47)
-1486CC20 (41.7)a10 (21.3)
CT23 (47.9)24 (51.1)
TT5 (10.4)a13 (27.7)
1174GG20 (41.7)a10 (21.3)
GA23 (47.9)24 (51.1)
AA5 (10.4)a13 (27.7)
2848AA19 (39.6)a9 (19.1)
AG24 (51.1)25 (53.2)
GG5 (10.4)a13 (27.7)
aP < 0.05
Table 5 Haplotype frequencies in ulcerative colitis cases and disease-free controls for Toll-like receptor 9 single nucleotide polymorphisms at -1486, 1174, 2848 n (%)
HaplotypeUC (n = 96)Controls (n = 94)
-148611742848
CGA62 (64.6)a43 (45.7)
TAG33 (34.4)a50 (53.2)
CGG1 (1.04)1 (1.06)
aP < 0.05
Table 6 Diplotype frequencies in ulcerative colitis cases and disease-free controls for Toll-like receptor 9 single nucleotide polymorphisms at -1486, 1174, 2848 n (%)
DiplotypeUC (n = 48)Controls (n = 47)
-148611742848
CCGGAA19 (39.6)a9 (19.1)
CCGGAG1 (2.1)1 (2.1)
CTGAAG23 (47.9)24 (51.1)
TTAAGG5 (10.4)a13 (27.7)
aP < 0.05
Table 7 Linkage disequilibrium among single nucleotide polymorphisms of Toll-like receptor 9 in ulcerative colitis cases and disease-free controls
SNPsUC (n = 48)
Controls (n = 47)
|D’|r2|D’|r2
-1486 T/C1174 A/G1111
-1486 T/C2848 G/A10.952210.9581
1174 A/G2848 G/A10.952210.9581